17-alpha-hydroxyprogesterone has been researched along with Breast Neoplasms in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (40.00) | 18.7374 |
1990's | 6 (40.00) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Kar, SP; Nounu, A; Relton, CL; Richmond, RC | 1 |
Day, NE; Dowsett, M; Dunning, AM; Easton, DF; Folkerd, E; Healey, CS; Kelemen, L; Luben, RN; Novik, KL; Ogata, S; Pharoah, PD; Ponder, BA; Tee, L | 1 |
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
Bodrogi, L; Fehér, T; Ribai, Z; Vallent, K | 1 |
Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE | 1 |
Carella, MJ; Dimitrov, NV; Gossain, VV; Rovner, DR; Srivastava, L | 1 |
Bucciante, G; Maggino, T; Pirrone, F; Velluti, F | 1 |
Castilla, JA; Herruzo, A; Marcos, C; Menjón, S; Ramírez, A | 1 |
Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ | 1 |
Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A | 1 |
Bennet, A; Caron, P; Carton, M; Gorguet, B; Martel, P; Roche, H | 1 |
Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E | 1 |
Cantwell, BM; Dowsett, M; Harris, AL | 1 |
Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van der Ploeg, E; van Veelen, H; Willemse, PH | 1 |
Freidenberg, GR; Horwitz, KB | 1 |
2 trial(s) available for 17-alpha-hydroxyprogesterone and Breast Neoplasms
Article | Year |
---|---|
Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Aldosterone; Aminoglutethimide; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Middle Aged; Postmenopause; Progesterone | 1994 |
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen | 1989 |
13 other study(ies) available for 17-alpha-hydroxyprogesterone and Breast Neoplasms
Article | Year |
---|---|
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genome-Wide Association Study; Gonadal Steroid Hormones; Humans; Hydrocortisone; Longitudinal Studies; Mendelian Randomization Analysis; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 2022 |
Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Androstenedione; Aromatase; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Case-Control Studies; Catechol O-Methyltransferase; Cytochrome P-450 CYP1B1; England; Estradiol; Estrone; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Gonadal Steroid Hormones; Humans; Linear Models; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Postmenopause; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Role of human adipose tissue in the production and metabolism of steroid hormones.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estrogens; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Obesity; Progesterone; Radioimmunoassay; Testosterone | 1982 |
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cosyntropin; Dehydroepiandrosterone; Drug Administration Schedule; Drug Therapy, Combination; Estrone; Female; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged | 1983 |
The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Aged; Androgens; Body Mass Index; Body Weight; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Obesity; Pyrones; Regression Analysis; Risk Factors; Sex Hormone-Binding Globulin | 1993 |
Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Exudates and Transudates; Female; Fibrocystic Breast Disease; Humans; Interleukin-1; Interleukin-8; Middle Aged; Potassium; Regression Analysis; Risk Assessment; Risk Factors; Sodium; Testosterone; Tumor Necrosis Factor-alpha | 1999 |
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles | 1991 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Thyroxine; Triiodothyronine | 1991 |
Mammary ovarian metastases with stroma cell hyperplasia and postmenopausal virilization.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Carcinoma; Female; Humans; Hydroxyprogesterones; Hyperplasia; Menopause; Middle Aged; Muscle, Smooth; Ovarian Neoplasms; Ovary; Receptors, Estradiol; Receptors, Progesterone; Testosterone; Virilism | 1990 |
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Aged; Androstenedione; Breast Neoplasms; Cosyntropin; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Metyrapone; Middle Aged | 1985 |
Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Dexamethasone; DNA, Neoplasm; Drug Resistance; Estradiol; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Kinetics; Norpregnadienes; Promegestone; Receptor, Insulin; Receptors, Progesterone | 1985 |